Senior insider sale
President and CEO at SOLENO THERAPEUTICS INC — senior position signals high conviction
$38.30M
767.13K shares
What this filing means
ANISH BHATNAGAR plans to sell 767.13K shares of SOLENO THERAPEUTICS INC valued at approximately $38.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2025ACC: 0001415889-25-009076
DirectorOfficer· President and CEO
Since Jan 2019
767.13K
Shares to sell
$38.30M
Approx. market value
746.04K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Stock option exercises
Cash
3/27/2025
512.29KVesting of Restricted Stock Units - See Remarks
Equity Compensation
3/26/2025
233.75KTotal acquired746.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2025 | Stock option exercises Cash | 512.29K | — |
3/26/2025 | Vesting of Restricted Stock Units - See Remarks Equity Compensation | 233.75K | — |
| Total | 746.04K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10.15K
Market value
$468.9K
1/3/2025
—Completed
Units to sell
10.94K
Market value
$496.6K
1/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
746.04K
Market value
$37.34M
3/27/2025
Total
Units
767.13K
Value
$38.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/3/2025 | 10.15K | $468.9K | — | Completed |
1/2/2025 | 10.94K | $496.6K | — | Completed |
| Planned — Approximate Date | ||||
3/27/2025 | 746.04K | $37.34M | NASDAQ | Planned |
| Total | 767.13K | $38.30M | ||